Multi-institutional study of mesonephric-like adenocarcinoma: its clinicopathological characteristics and histogenetic association with ectopic endometrium
To explore the clinicopathological features and origin of mesonephric-like adenocarcinomas (MLAs), 83 cases diagnosed or suspected to be MLAs were collected from various institutions in Japan. We clearly classified 78 as MLAs (uterus: 47, ovary: 31) and 5 as non-MLAs (all ovary) based on our morphological and immunohistochemical criteria. In uterine MLAs (uMLAs), lymphovascular space invasion was an independent prognostic factor for progression-free survival (PFS) (P = 0.03). Patients with uMLAs had significantly shorter PFS and overall survival (OS) than those diagnosed with endometrial endometrioid carcinomas (EECs) (P < 0.0001 and P < 0.001, respectively) and comparable PFS and OS to those with copy number-high tumors. PFS and OS of ovarian MLAs (oMLAs) were similar to those of ovarian endometrioid carcinomas (OECs) overall but worse for patients with stage II-IV. Endometriosis was observed with oMLAs as often as with OECs (94% vs 93%, respectively). Adenomyosis was more frequently observed with uMLAs than with EECs (62% vs 28%, respectively, P = 0.0005). Six uMLAs were confined to the myometrium and adjacent to adenomyosis. In an analysis of molecularly speculated origin, among 29 oMLAs harboring a KRAS hotspot mutation, 23 (79%) instances of endometriosis in the background had the same mutation. Among 36 uMLAs carrying the KRAS hotspot mutation, common mutations were observed in 12 (33%) instances of adjacent adenomyosis (12/21 [67%] of adenomyosis). These findings suggest a histogenetic link between MLAs and ectopic endometrium, implicating both ovarian endometriosis and adenomyosis in MLA pathogenesis, with potential clinical significance.
Authors
- Morihiro Higashi
- Junichi Shiraishi (ORCID: https://orcid.org/0000-0003-1520-835X)
- Fumi Kawakami (ORCID: https://orcid.org/0000-0002-3242-0988)
- Yu Miyama (ORCID: https://orcid.org/0000-0001-5901-6961)
- Kousuke Uranishi
- Yoshinobu Maeda
- Takako Kiyokawa (ORCID: https://orcid.org/0000-0002-7407-6345)
- Eiji Kudo (ORCID: https://orcid.org/0000-0002-9427-6619)
- Akiko Tonooka (ORCID: https://orcid.org/0000-0001-6095-578X)
- Kozue Ito
- Masataka Hirasaki (ORCID: https://orcid.org/0000-0002-9647-2568)
- Masanori Yasuda (ORCID: https://orcid.org/0000-0002-0769-360X)
- Yohei Kawasaki (ORCID: https://orcid.org/0000-0002-7474-7647)
- Sachiko Minamiguchi (ORCID: https://orcid.org/0000-0002-5800-6769)
- Yumiko Yasuhara (ORCID: https://orcid.org/0000-0003-4391-186X)
- Hiroshi Kajiwara (ORCID: https://orcid.org/0000-0002-3463-8059)
- Kosei Hasegawa (ORCID: https://orcid.org/0000-0002-1903-7001)
- Tetsuya Shimada (ORCID: https://orcid.org/0000-0001-5187-7177)
- Yoshiaki Kawano (ORCID: https://orcid.org/0000-0003-3264-3783)
- Yoshiki Mikami (ORCID: https://orcid.org/0000-0002-5759-6736)
- Yuzuru Kondo
- Nasa Okazaki
Institutions
- Jikei University School of Medicine (JP)
- Tokai University (JP)
- University of the Ryukyus (JP)
- National Defense Medical College Hospital (JP)
- Tokyo Medical Center (JP)
- Tokushima Prefectural Central Hospital (JP)
- Sakai Municipal Hospital (JP)
- Japanese Red Cross Kumamoto Hospital (JP)
- Toyama City Hospital (JP)
- Niigata Prefectural Niigata Minami High School (JP)
- Kyushu Hospital (JP)
- Matsuyama Red Cross Hospital (JP)
- Kumamoto University Hospital (JP)
- Saitama International Medical Center (JP)
- Japan Community Healthcare Organization (JP)
- National Hospital Organization (JP)
- Kasumigaura Medical Center (JP)
- Toyama University Hospital (JP)
- Kyoto University Hospital (JP)
- Social Insurance Saitama Chuo Hospital (JP)
- Japanese Foundation For Cancer Research (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1007/s00428-025-04286-0
- Primary Topic
- Endometriosis Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00